World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
23859
World Ranking
15193
National Ranking
193

Jean-Pierre Devogelaer publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jean-Pierre Devogelaer sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 403 publications — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jean-Pierre Devogelaer D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jean-Pierre Devogelaer sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 84 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Jean-Pierre Devogelaer is affiliated with the Université Catholique de Louvain in Belgium. Their research primarily spans fields including Medicine and Biochemistry, Genetics and Molecular Biology. Within these domains, their subfields of study focus notably on Oncology, Genetics, Orthopedics and Sports Medicine, Molecular Biology, and Nutrition and Dietetics.

The researcher's publication record highlights several main topics related to bone and connective tissue disorders, as well as cancer-related molecular pathways. Key areas of their work include Bone health and treatments, Connective tissue disorders research, Bone health and osteoporosis research, Bone Metabolism and Diseases, Vitamin K Research Studies, and Medical Imaging and Pathology Studies.

Jean-Pierre Devogelaer has contributed to a selection of recent papers reflecting diverse aspects of bone health and genetic diseases. Notable publications include:

  • Sclerostin-Antibody Treatment Decreases Fracture Rates in Axial Skeleton and Improves the Skeletal Phenotype in Growing oim/oim Mice (2020) - Calcified Tissue International
  • Gender-Related Impact of Sclerostin Antibody on Bone in the Osteogenesis Imperfecta Mouse (2021) - Frontiers in Genetics
  • Randomised trial of genetic testing and targeted intervention to prevent the development and progression of Paget's disease of bone (2023) - Annals of the Rheumatic Diseases
  • Genetic Screening of ZNF687 and PFN1 in a Paget's Disease of Bone Cohort Indicates an Important Role for the Nuclear Localization Signal of ZNF687 (2023) - Calcified Tissue International
  • A Panel-Based Sequencing Analysis of Patients with Paget's Disease of Bone Suggests Enrichment of Rare Genetic Variation in regulators of NF-κB Signaling and Supports the Importance of the 7q33 Locus (2021) - Calcified Tissue International

Their research outputs have been published in journals with several recurring venues, including:

  • Calcified Tissue International
  • Frontiers in Genetics
  • Annals of the Rheumatic Diseases
  • Osteoporosis International
  • Aging Clinical and Experimental Research

Collaborations form a significant part of their work. Frequent co-authors include Maria Luisa Brandi, Jean-Yves Reginster, Mickaël Cardinal, Thomas Roels, and Sébastien Lafont. These collaborative engagements reflect contributions across overlapping research themes in bone biology and related medical fields.

Best Publications

  • Ten years' experience with alendronate for osteoporosis in postmenopausal women.

    Henry G. Bone;David Hosking;Jean-Pierre Devogelaer;Joseph R. Tucci

  • Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis : Treatment of peripheral osteoporosis (TROPOS) study

    J Y. Reginster;E Seeman;M C. De Vernejoul;S Adami

  • Intravenous zoledronic acid in postmenopausal women with low bone mineral density.

    Ian R. Reid;Jacques P. Brown;Peter Burckhardt;Zebulun Horowitz

  • Efficacy and Safety of Daily Risedronate in the Treatment of Corticosteroid-Induced Osteoporosis in Men and Women: A Randomized Trial*

    David M. Reid;Rodney A. Hughes;Roland F. J. M. Laan;Nancy A. Sacco-Gibson

  • Effects of Teriparatide Versus Alendronate for Treating Glucocorticoid-Induced Osteoporosis Thirty-Six-Month Results of a Randomized, Double-Blind, Controlled Trial

    Kenneth G. Saag;Jose R. Zanchetta;Jean-Pierre Devogelaer;Robert A. Adler

  • Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial.

    David M Reid;Jean-Pierre Devogelaer;Kenneth Saag;Christian Roux

  • Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity.

    F A Houssiau;C Lefebvre;M Vanden Berghe;M Lambert

  • Effects of Dairy Products Consumption on Health: Benefits and Beliefs—A Commentary from the Belgian Bone Club and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases

    Serge Rozenberg;Jean-Jacques Body;Olivier Bruyère;Pierre Bergmann

  • Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial.

    Peter Alexandersen;Anne Toussaint;Claus Christiansen;Jean-Pierre Devogelaer

  • ETIDRONATE AND THE RISK OF FRACTURES

    C Nagant de Deuxchaisnes;J P Dufour;J P Devogelaer;J P Huaux

  • Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis

    J.P. Devogelaer;H. Broll;R. Correa-Rotter;D.C. Cumming

  • Role of alendronate in therapy for posttraumatic complex regional pain syndrome type I of the lower extremity.

    Daniel-Henri Manicourt;Jean-Pierre Brasseur;Yves Boutsen;Geneviève Depreseux

  • Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.

    Yves Boutsen;Jacques Jamart;Walter Esselinckx;Jean-Pierre Devogelaer

  • Risedronate Increases Bone Density and Reduces Vertebral Fracture Risk Within One Year in Men on Corticosteroid Therapy

    David M Reid;S. Adami;J. P. Devogelaer;A. A. Chines

  • Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial

    Nick Bishop;Silvano Adami;S Faisal Ahmed;Jordi Antón

  • Effects of diclofenac, aceclofenac and meloxicam on the metabolism of proteoglycans and hyaluronan in osteoarthritic human cartilage.

    Laurent Blot;Annette Marcelis;Jean-Pierre Devogelaer;Daniel-Henri Manicourt

  • Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate.

    David Hosking;Kenneth Lyles;Jacques P Brown;William D Fraser

  • Intravertebral vacuum cleft: changes in content after supine positioning.

    Jacques Malghem;Baudouin Maldague;M A Labaisse;Grégoire Dooms

  • Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club.

    Pierre Bergmann;Jean-Jacques Body;Steven Boonen;Yves Boutsen

  • Genome-wide association identifies three new susceptibility loci for Paget's disease of bone.

    Omar M.E. Albagha;Sachin E. Wani;Micaela R. Visconti;Nerea Alonso

Frequent Co-Authors

Jean-Yves Reginster
Jean-Yves Reginster University of Liège
Olivier Bruyère
Olivier Bruyère University of Liège
Kenneth G. Saag
Kenneth G. Saag University of Alabama at Birmingham
Jean-Jacques Body
Jean-Jacques Body Université Libre de Bruxelles
Cyrus Cooper
Cyrus Cooper University of Southampton
Chak Sing Lau
Chak Sing Lau University of Hong Kong
Steven Boonen
Steven Boonen KU Leuven
René Rizzoli
René Rizzoli Geneva College
John A. Kanis
John A. Kanis Australian Catholic University
Christian Roux
Christian Roux Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative and complementary education routes in healthcare can enhance your career options in the medical field. Whether you’re interested in nursing, mental health, or healthcare management, accredited online programs offer accessible pathways that fit diverse schedules and backgrounds.

For nurses seeking career advancement, easiest online dnp programs provide a flexible way to achieve a Doctor of Nursing Practice without extensive time on campus. If you’re just starting out, enrolling in an lpn program online can quickly get you into the workforce with essential nursing skills.

Those interested in mental health may consider psych nurse practitioner programs, which focus on psychiatric mental health and provide opportunities for specialization. If your interest lies in leadership or administration, choosing the cheapest online health science degree can help build a solid foundation in healthcare management while minimizing educational costs.

Evaluating these online program options can help you find the best fit for your career goals while navigating the growing field of healthcare.

Best Scientists Citing Jean-Pierre Devogelaer

Trending Scientists

Recently Published Articles